Patients with a history of thyroid cancer or medullary thyroid carcinoma (MTC) should not use GLP-1 medications like semaglutide, as these drugs carry a boxed warning for potential thyroid C-cell tumor risk based on animal studies
Cycle Length Variations: Some of the women consuming Semaglutide report getting their menstrual cycles to be shorter or longer than usual which is a clear sign of irregularities caused by Semaglutide
Semaglutide (GLP-1) and its brand Ozempic are both effective options for weight loss, originally developed to manage type 2 diabetes
Check in monthly with your provider to fine-tune your medication and get the ongoing support you need to stay on track
Kuckelman, Novos senior vice president and general counsel, said Novo welcomes competition grounded in science, but it cannot stand by as advertising continues to withhold the information patients need, saying Lillys misleading ads leave patients with the mistaken impression that Lilly's drugs are vastly superior, and that is simply not true. In a statement earlier this week, Lilly said it stood by its ads, calling them "truthful," "transparent" and grounded in the most direct scientific evidence available - exactly what patients deserve. What Did Novo Nordisk Allege In Its Lawsuit